Simple Peptide
Tesofensine
$170.00
10% OFF ORDERS OVER $200
Availability: 156 in stock (can be backordered)
Tesofensine is a serotonin–noradrenaline–dopamine reuptake inhibitor from the phenyltropane family of drugs, which is being developed for the treatment of obesity. Tesofensine was originally developed by a Danish biotechnology company, NeuroSearch, who transferred the rights to Saniona in 2014.
Tesofensine is already heavily discounted and is not eligible for volume discounting.
Clinical Data:
Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons
Anti-obesity Drugs: From Animal Models to Clinical Efficacy
Storage and Handling:
To preserve the stability and integrity of this product, store it in a cool, dry place, protected from direct sunlight. Handle Tesofensine with care and follow standard laboratory practices to ensure precise and reliable results.
Disclaimer:
This product is not intended for human or animal consumption. It is exclusively designed for research by qualified professionals. Any potential therapeutic applications should undergo rigorous exploration, validation, and further research, including clinical trials.
